Lumexa Imaging Holdings Statistics
Total Valuation
LMRI has a market cap or net worth of $768.65 million. The enterprise value is $1.68 billion.
Important Dates
The last earnings date was Tuesday, May 12, 2026, after market close.
| Earnings Date | May 12, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
LMRI has 96.08 million shares outstanding. The number of shares has increased by 11.79% in one year.
| Current Share Class | 96.08M |
| Shares Outstanding | 96.08M |
| Shares Change (YoY) | +11.79% |
| Shares Change (QoQ) | +27.39% |
| Owned by Insiders (%) | 1.35% |
| Owned by Institutions (%) | 37.15% |
| Float | 22.10M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 9.86 |
| PS Ratio | 0.75 |
| Forward PS | 0.70 |
| PB Ratio | 1.28 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 124.42 |
| P/OCF Ratio | 22.63 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 19.64, with an EV/FCF ratio of 272.72.
| EV / Earnings | n/a |
| EV / Sales | 1.63 |
| EV / EBITDA | 19.64 |
| EV / EBIT | 37.85 |
| EV / FCF | 272.72 |
Financial Position
The company has a current ratio of 1.40, with a Debt / Equity ratio of 1.61.
| Current Ratio | 1.40 |
| Quick Ratio | 1.30 |
| Debt / Equity | 1.61 |
| Debt / EBITDA | 8.43 |
| Debt / FCF | 156.60 |
| Interest Coverage | 0.42 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 2.77% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | $237,743 |
| Profits Per Employee | -$8,697 |
| Employee Count | 4,335 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, LMRI has paid $12.87 million in taxes.
| Income Tax | 12.87M |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 9.60 |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 41.93 |
| Average Volume (20 Days) | 1,070,526 |
Short Selling Information
The latest short interest is 3.21 million, so 3.34% of the outstanding shares have been sold short.
| Short Interest | 3.21M |
| Short Previous Month | 3.89M |
| Short % of Shares Out | 3.34% |
| Short % of Float | 14.53% |
| Short Ratio (days to cover) | 3.79 |
Income Statement
In the last 12 months, LMRI had revenue of $1.03 billion and -$37.70 million in losses. Loss per share was -$0.49.
| Revenue | 1.03B |
| Gross Profit | 155.24M |
| Operating Income | 44.52M |
| Pretax Income | -24.83M |
| Net Income | -37.70M |
| EBITDA | 85.77M |
| EBIT | 44.52M |
| Loss Per Share | -$0.49 |
Full Income StatementBalance Sheet
The company has $51.23 million in cash and $967.45 million in debt, with a net cash position of -$916.22 million or -$9.54 per share.
| Cash & Cash Equivalents | 51.23M |
| Total Debt | 967.45M |
| Net Cash | -916.22M |
| Net Cash Per Share | -$9.54 |
| Equity (Book Value) | 599.62M |
| Book Value Per Share | 6.24 |
| Working Capital | 63.96M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $33.97 million and capital expenditures -$27.79 million, giving a free cash flow of $6.18 million.
| Operating Cash Flow | 33.97M |
| Capital Expenditures | -27.79M |
| Depreciation & Amortization | 41.25M |
| Net Borrowing | -384.07M |
| Free Cash Flow | 6.18M |
| FCF Per Share | $0.06 |
Full Cash Flow StatementMargins
Gross margin is 15.06%, with operating and profit margins of 4.32% and -3.66%.
| Gross Margin | 15.06% |
| Operating Margin | 4.32% |
| Pretax Margin | -2.41% |
| Profit Margin | -3.66% |
| EBITDA Margin | 8.32% |
| EBIT Margin | 4.32% |
| FCF Margin | 0.60% |
Dividends & Yields
LMRI does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -11.79% |
| Shareholder Yield | -11.79% |
| Earnings Yield | -4.90% |
| FCF Yield | 0.80% |
Analyst Forecast
The average price target for LMRI is $18.00, which is 125.00% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $18.00 |
| Price Target Difference | 125.00% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 8 |
| Revenue Growth Forecast (5Y) | 5.72% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
LMRI has an Altman Z-Score of 0.92 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.92 |
| Piotroski F-Score | 5 |
